One of the big issues is that, being a new area, just how you target this disease and via what biomarkers is still unclear. Bioclinica, a biopharma services company, is launching a new service aimed at using medical imaging in tests designed to push on with trial work in this area.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,